# FDA Inspection 1166201 - Symbiosis (Biopharm GmbH) - April 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/symbiosis-biopharm-gmbh/4c755587-42ea-4e36-a423-1ce84774d65b
Source feed: FDA_Inspections

> FDA Inspection 1166201 for Symbiosis (Biopharm GmbH) on April 29, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166201
- Company Name: Symbiosis (Biopharm GmbH)
- Inspection Date: 2021-04-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 831533 - 2013-04-23](https://www.keypedia.com/records/fda_inspections/symbiosis-biopharm-gmbh/74e29a1e-8885-4836-8394-dcb61cf7c57e)

Company: https://www.keypedia.com/companies/symbiosis-biopharm-gmbh/33ada2db-2cc0-4b3b-b99d-e08cf3021c89

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c